U.K. officials privately admitted AstraZeneca blood clot risk was “potentially very serious,” then let trial on children as young as 6 continue

U.K. officials privately admitted AstraZeneca blood clot risk was “potentially very serious,” then let trial on children as young as 6 continue

U.K. government advisers privately admitted in May 2021 that AstraZeneca’s COVID-19 vaccine carried a potentially very serious blood clot risk.
They still allowed a clinical trial giving the shot to 262 children, some as young as 6, to continue.
The advisers acknowledged the vaccine’s direct benefit to children was remote and low compared with the risk.
By then, Britain’s medicines regulator had logged 332 reports of the clotting condition, including 58 deaths.
Britain has now accepted that its vaccine injury compensation scheme needs reform but has offered no timeline.

Read Full Article: https://www.naturalnews.com/2026-10-28-astrazeneca-blood-clot-risk-potentially-very-serious.html